Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00).

Anticancer Drugs. 2004 Jun;15(5):489-94.

Vázquez S1, Grande C, Amenedo M, Fírvida JL, Lázaro M, Alonso G, Curiel T, Huidobro G, Mel JR, Ramos M.

Vázquez S1 et al.
Ver